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                                     INTRODUCTION 
 
                       A liver abscess is a suppurative cavity in the liver resulting 
from the invasion and multiplication of microorganisms, entering directly 
from an injury through the blood vessels or by the way of the biliary ductal 
system. Liver abscesses are most commonly due to pyogenic, amoebic or 
mixed infections. Less commonly these may be fungal in origin. 
Amoebic liver abscess is common in tropical and subtropical  
regions, caused by Entamoeba histolytica infestation. 3-10% of amoebiasis 
patients may develop amoebic liver abscess. It affects younger individuals 
when compared to pyogenic liver abscess. The amoebic liver abscess has 
male preponderance but the pyogenic liver abscess has equal sex 
incidence. 
 
Major portions of the reticuloendothelial system in the human body 
present in the liver, hence handles the continuous low level exposure to 
enteric bacteria. It is received through portal circulation. Non viral 
infections are unusual since high level reticuloendothelial cells in the liver. 
 
 Right lobe the liver is commonly affected due large volume and 
major blood supply. About 90% of the right lobe abscess are solitary and 
about only 10% of the left lobe abscess are solitary. The abscess may 
follow the suppurative process anywhere in the body. 
 
Pyogenic liver abscess are caused by bacteria. The infective foci 
arise from  
 
a) biliary tract  
 
 
b) portal circulation  
 
 
c) haematogenous via hepatic artery  
 
 
d) direct extension from intra abdominal regions  
 
 
e) trauma.  
 
 
Of these biliary pathology is the most common cause. 
 
 
In amoebic liver abscess the most common symptom is abdominal 
pain. In pyogenic liver abscess fever is the most frequent symptom. Large 
abscesses are seen mainly in the amoebic liver abscess. 
 
Ultrasonography is the main modality to diagnose the liver abscess. 
CT scan abdomen can detect even less than 0.5 cm abscess. Pus culture 
and sensitivity confirms pyogenic etiology. Serological tests are 
confirmatory to diagnose amoebic liver abscess. 
 
            In amoebic liver abscess, medical management is useful in most of 
the times. In pyogenic liver abscess the main treatment should be drainage 
method and antimicrobials. 
 Liver abscess treated by following methods : 
 
 
1. Drugs alone.  
 
 
2. USG Guided needle aspiration. 
 
 
3. Percutaneous pigtail catheter drainage. 
 
 
4. Laparoscopic drainage.  
 
 
5. Open surgical drainage.  
 
 
In this study 52 randomly selected cases are studied and mainly focused 
on the age distribution, type & site of the liver abscess, symptoms & signs, 
size & number of the abscess. 
 
In this study the patients with abscess size more than 5 cm are treated 
with needle aspiration, percutaneous drainage, laparoscopic drainage 
methods & laprotomy. Outcomes are studied  in these patients under the 
following criteria 
 
 Duration of drainage 
 Time for 50% reduction of the abscess cavity  
 Duration of hospital stay 
 Secondary procedure done 
 Complications & follow up
 Recurrence
  
 
 
 
 
 
 
 
 
 
 
                               Aim Of The Study 
 
 
  
 
                                          AIM OF THE STUDY 
 
 
 
 
1. To study  about the clinical presentations, various treatment modalities 
of  the patients diagnosed as liver abscess in our institution. 
2.  To identify  the outcomes in terms of clinical improvement, duration of 
hospital stay & recurrence.  
3.  To study about the morbidity  & long term follow up. 

 
 
PLACE OF STUDY: 
        Department Of General Surgery, in GOVT STANLEY MEDICAL 
COLLEGE AND HOSPITAL, CHENNAI -1 
 
DURATION OF STUDY: 
       8months   (February 2016 to September 2016) 
  
  
 
 
 
 
 
 
 
 
 
         Review Of Literature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                           REVIEW OF LITERATURE 
 
 
ANATOMY OF THE LIVER: 
 
 
Among the abdominal viscera liver is the largest organ occupying 
the right hypochondrium and the epigastric region. The liver involved in 
all metabolic activities which are involved in homeostasis, nutrition and 
immune mechanism. It removes toxic materials in the body and regulates 
blood glucose levels and lipid metabolism. The liver stores vitamins, iron 
and micronutrients. 
 
It has superior, anterior, right, posterior and inferior surfaces. 
Grossly it is divided in to four lobes as right, left, quadrate, caudate lobes. 
Currently, the liver functionally divided in to eight segments based on 
Couinaud’s proposal. The abscess location determines the therapeutic 
decisions for the method of drainage. Comparing the left lobe, right lobe is 
easier to drain percutaneously. Because the superior mesenteric vein 
preferentially drains in the right lobe of the liver. So the greater amount of 
the blood goes to the right lobe leads to abscess formation common in the 
right lobe. 
 
AMOEBIC LIVER ABSCESS: 
 
 
HISTORY:  
 
 
Leish recognised the first amoebae in colonic lesions with dysentery
 Twenty six tropical abscess were described in autopsy series with 
dysentery. Between the year 1849-1919, many species of amoeba found in 
the human beings were Entamoeba coli, Entameba gingivalis,, Iodamoeba 
butschlii, Entamoeba hartmani. In 1903, Schaudin named the species 
Entamoeba histolytica. The two distinct species identified which are 
morphologically indistinguishable- entamoeba histolytica and entamoeba 
dispar. Entamoeba dispar is the only pathogen associated with 
asymptomatic carrier state. 
 
 
 
INCIDENCE: 
 
 
Amoebiasis occurs globally but the incidence is highest at the 
tropical and subtropical areas. Sometimes those who are serologically 
positive for amoebiasis and stool culture shows positive result may not 
show clinical symptoms. Such asymptomatic patients are now thought to 
be due to Entamoeba dispar. Approximately, 10 percent of patients with 
intestinal amoebiasis are prone to develop amoebic liver abscess. Amoebic 
liver abscess due to heavy alcohol consumption in males, hormonal 
influence in women before menstruation and iron deficiency anemia 
protect from abscess in menstruating women. 
 
EPIDEMIOLOGY: 
 
 
It commonly affect males of age group 30 to 50 years. The reason 
behind this is due to alcohol induced hepatocellular damage produces 
nidus for seeding of infection from intestine through portal venous system. 
There is association of amoebic infection with poor sanitation, hot climate, 
lack of hygiene and overcrowded living conditions in lower socioeconomic 
groups of developing countries.  
 
The infection transmitted mainly through fecal-oral route following 
contamination of food by flies, handling of the food after contamination if 
there is unhygienic practices are followed in the family . If human faeces 
are used as fertilizer it may contaminate the water and raw sewage and if 
the unclean water is used for freshening the food.  
 
Amoebic liver abscess in developed countries occurs in travellers by 
E.Histolytica after stay of more than one month duration in endemic 
regions. Immuno compromised state due to HIV infection also increase the 
chance of amoebic liver abscess. Diseases where the cell mediated 
immunity is reduced also increase the disease occurrence. The common 
organism involved in homosexual amoebiasis is Entamoeba dispar in 
temperate climates. 
  
 
 
RISK FACTORS: 
 
 
 Alcoholism 


 Malnutrition 


 Immunocompromised states like steroids usage, AIDS


 Old age 


 Malignancy 


 Pregnancy 


 Recent travel to tropical regions 
 
 


HOST RESPONSE:  
         Trophozoites contain ribosomal, lysosomal, cytoplasmic materials  
and contents from trophozoite surface in subcellular fractions eliciting  
antibody response has been detected by antigenic determinents. In infected  
patients the organism is detected in feces, serum, and materials obtained  
from liver abscess. 
      Production of immunoglobulin G is the complex humoral immune  
response to amoebic infection. Immunoglobulin M also produced as an  
immune response. But the immunoglobulin E is not produced. Immune  
serum and immune globulin against amoebic infection have lytic effect on  
amoeba.  
      In human being, humoral immunity is active against amoebiasis  prior  
to the invasive disease. Cell mediated immunity is active against the  
invasive amoebiasis. Following amoebic infection the antigen sensitize the  
T-lymphocytes and induce its proliferation produce lymphokines and  
activates the macrophages. Malnutrition and alcohol intake predispose the  
development of invasive amoebiasis. It is seen predominantly in male  
population.  
 
HOST FACTORS:  
      Human beings are the major reservoir host. Transmission occurs 
interpersonally through flies and fecal contamination of water. The  
pathogen Entamoeba dispar is common in those who are Homosexuals.  
But the Entamoeba dispar is most common in female population, those 
who are menstruating are not prone for infection but the reason is not 
known.  
      Because of low iron and presence of protective IgA in the immature 
milk of lactating women the breast fed children are less commonly 
affected. The country liquor as it contains more iron it causes invasive 
amoebiasis frequently. Poor socio economic status and adults of young age 
group are commonly affected than elder individuals. The protective 
activity against liver abscess of menstruation is lost during pregnancy.  
 
ENTAMOEBA HISTOLYTICA 
 
 
Entamoeba histolytica (19) is a protozoan of anaerobic in nature. It 
infects human and primates. 
 
It is a single celled parasite causes intestinal amoebiasis with 
severity range from asymptomatic to discomfort, diarrhoea, dysentery, 
liver abscess, amoebic encephalitis according to 
 
1. Immunity of the patient  
 
 
2. State of nutrition of the patient  
 
 
3. Amount of infective dose  
 
 
4. Potency of the infective agent  
 
 
Only in some cases the infection is restricted to the intestinal lumen. 
The non invasive form is having nucleus and number of vesicles in the 
granular cytoplasm. Although the trophozoites are anaerobic they can 
survive in the environmental conditions of low oxygen tension. Under 
certain environments the trophozoites release their vacuoles and around -
themselves secrete a chitinous wall and forms cysts. Each cyst become 
quadrinucleate after cell division and mature. These cysts are infective 
stage of the parasite and the cysts in the feces are viable for several days. 
The trophozoites are destroyed by stomach gastric juice and they will not 
alive outside the human host. The factors which stimulate the trophozoites 
to become invasive are not known. Compared to non invasive trophozoites 
the invasive trophozoites are larger in size and diameter. 
 
The pathogenicity may be increased when the bacterial disease is 
associated. To understand wide variation in the disease, the most 
promising advance is the association between the zymodemes and the 
pathogenicity. An immunofluorescent technique has been reported to 
distinguish non pathogenic and pathogenic forms. Light or electron 
microscopy cannot distinguish the non pathogenic and pathogenic forms. 
 
 
 
         The hallmark investigations for intestinal amoebiasis of invasive form 
are demonstration of the parasite in the stool, rectal mucosal scrapings, 
specimens containing trophozoites with ingested red cells. But the cysts 
and trophozoites present in the stool is not a confirmatory evidence of 
invasive disease. 
 
 
MORPHOLOGY 
 
 
TROPHOZOITE : 
 
 
It has a diameter of 15-30 micrometers. The invasive forms are 
more active and have the diameter of 50 micro meter. It is uninucleate, 
facultative anaerobe and has a limiting membrane which contains double 
layer surrounded with external glycocalyx of 20-30 micrometer in 
diameter. The strains isolated from patients of 18 in various parts of the 
 
world. Out of these, seven are pathogenic which are isolated from patients 
of mucosal ulceration and hepatic abscess. For mobility it has 
pseudopodes. Trophozoites has ability to multiply but are not infective and 
cysts will not multiply. Trophozoites are responsible for amoebic 
dysentery, hepatitis, encephalitis. It contains fine granular endoplasm with 
ingested red blood cells and contains one nucleus only. 
 
 
 
 
CYST: 
 
 
These are infective forms of diameter 8-10 micrometers with 
retractile wall. They have more than one nucleus. They are Quadrinucleate 
form, after ingestion they will become metacystic stage another nuclear 
division occur and forms eight uninucleate trophozoites and complete the 
life cycle. Cyst can survive in the faecal material lodged under the nail for 
45 minutes and can survive for up to one month in the soil at 10
o
C. Rough 
chemical and physical environment does not destroy the cysts, because the 
cysts are highly resistant to such situations. But they are rapidly destroyed 
by drying, iodine of 200 ppm, heat of greater than 68
o
C. They are not 
killed by chlorination which is used for drinking water purification. 
 
Definitive host is human. No intermediate host or vectors for 
Entamoeba histolytica. 
LIFE CYCLE: 
 
 
Infective cysts from infective person are released into water or food. 
They are ingested by another person. In the stomach they are resistant to 
low pH. Cysts are excysted by components of bile and bicarbonate in the 
small intestine. Released trophozoites are carried to the cecum and 
adherent to the mucosal epithelium of the cecum. Trophozoites multiply by 
binary fission asexually. Then stops multiplying and encystations occurs. 
These cysts are released in the faeces. Mixtures of trophozoites and cysts 
are released in the feces of symptomatic patients (dysentery).  
 
 
PATHOPHYSIOLOGY: 
 
 
Infection begins after ingestion of the quadrinucleate cyst of the 
Entamoeba histolytica following contamination of the food and water with 
the faecal material. The acidic pH in the stomach does not destroy the cyst 
and excystation happens in the small intestine in the environment of 
alkaline and neutral pH followed by release of trophozoite form of the 
pathogen. 
 
The virulence factors leading the course of the disease process are a 
parasite protein in the surface Lectin, amoebapores and proteases 
especially cysteine. The surface galactose/N-acetylgalactosamine 
(GalNAc) lectin mediate the adhesion of the trophozoite to the colonic 
walls. When it attaches to the glycoproteins present in the intestine 
forming persistant infection. It results in caspase activation, activation of 
caspase 3 in the apoptotic pathway involved in cell killing and formation 
of the abscess. The amoebapores which are small peptides released by 
trophozoites involved in the breaking up of the lipid bilayer of mucosal 
epithelium leads to destruction of the barrier function of the mucosa forms 
the portal of entry to the organism. Its pathogenicity is due to colloid 
osmotic lysis of the cell. 
 
The cysteine proteases involved in the pathogenesis of extra cellular 
degradation and cell monolayer disruption. The invasion extends to 
submucosal layer spreads laterally forming ulcers which are Flask shaped.  
 
PATHOGENICITY: 
 
 
ENTAMOEBA CYSTS ( in water, soil, food under moist conditions) 
 
 
Ingestion of the cyst 
 
 
Excystation occur in the lumen of the colon and forms trophozoites 
 
 
Invades the intestinal mucosa 
 
 
Multiplying in the margins of the ulcer 
 
 
Enter through mesenteric venules 
 
 
                    Through portal venous system causing Liver abscess 
 SITE OF THE ABSCESS AND ITS CONTENTS: 
 
 
Because of the larger volume and receiving maximum amount of 
blood supply the right lobe of the liver is commonly involved (1,2,19,20). 
It affects the right lobe near the dome of the diaphragm. The amoebic liver 
abscesses are well defined lesions containing yellow brown fluid later it 
becomes orange brown colour anchovy sauce appearance (21,24). The 
fluid contains necrotic liver tissue and blood. It is odourless contains few 
or no neutrophils. The edge of the lesion contains necrotic material 
hepatocytes and inflammatory cells. In the aspirate no amoeba will be 
found, they are mostly present in the periphery of the abscess. There will 
be periportal lysis of hepatic cells (21). 
 
          Surrounding the abscess, the unaffected part of the liver shows 
hyperaemia and edema which explains the hepatomegaly (24). Infection of 
the gallbladder and bile ducts does not occur, because the bile kills the 
parasite. Scarring will not occur after healing of the abscess. 
 
COMMUNUTY SCREENING PROCEDURES: 
 
 
The procedures done for parasitologic protocol are (25) 
 
 
1) The unfixed faecal samples which are unstained or stained with 
iodine examined microscopically  
 
2) Ritche’s fecal concentration of samples, fixed with formalin. 
 
3) Polyvinyl alcohol fixed stools are fixed with trichrome staining  
 
 
4) Robinson’s in vitro cultures  
 
 
5) Two stool antigen detecting tests  for E.Histolytica and E.dispar.  
 
 
6) Serological tests include enzyme immunoassay, indirect 
haemagglutination test and indirect immunofluorescence test.  
 
7) To identify zymodeme, starch gel isoenzyme electrophoresis of the 
stool samples can be done.  
 
 
 
IMMUNOLOGY AND VACCINE DEVELOPMENT (19) : 
 
The immunological reactions for the organism is both humoral and 
cellular. Some components are in the immunological process limit the 
disease process and some may exacerbate the disease. Recurrence of the 
amoebic abscess is rare. 
 
First line of defence against the parasite provided by innate 
immunity. Eventhough the complement is active against the parasite it 
cannot prevent the invasion of the E.histolytica, because the complement is 
absent in the gut mucosal secretions. Usually the initial host defence will 
be due to neutrophils, but the parasite kills these cells by producing a 
chemoattractant on contact. 
 The adoptive immunity is the second line of defense against 
E.Hitolytica. In this cell mediated immune response cytokines are 
produced (e.g interferon gamma, tumour necrosis factor alpha,and 
interleukin 4) these cells activate lymphocytes and macrophages. 
 
The local immune response IgA and serum IgG by Lectin protein 
causes non invasive and invasive infection of E.Histolytica. Serm IgG 
response does not provide immunity against the infection, but active 
against the future invasive disease. 
 
Acquired immunity against the parasite is due to mucosal immune 
response produced by amoebic antigens inducing the gut associated 
lymphoid tissue. These are considered to be primary vaccine candidates. 
The antibody response against the galactose lectin and protection against 
the amoebic liver abscess also reported. Codon optimized DNA vaccine 
against the galactose lectin subunit producing cellular immune response 
and serum antibodies are also reported. 
 
The  more  sensitive  and  specific  tests  among  these  to  distinguish 
 
E.Histolytica and E.Dispar are Robinson’s test and zymodeme 
identification. The most recent test to detect few (<5) cysts in the stool 
sample is DNA based PCR technique. It is a rapid test to perform and 
differentiate E.Histolytica and E.dispar without precultivation. To detect 
accurately the epidemiology of the two species PCR is the reliable test. 
 
 
 
CLINICAL PRESENTATION: 
 
 
The onset of clinical symptoms are slow and are present for several 
days or weeks before the patient comes for medical attention. The 
presentation is insidious onset lasting for two or more weeks. 
 
PAIN: 
 
 
Right hypochondrial pain is common in liver abscess for one to two 
weeks. This pain is due to stretching of the liver capsule by the 
abscess(19).The pain may referred to, right side chest, right shoulder. The 
pain is dull aching and constant. Seen in 90-93% of the patients. In the left 
lobe abscess the pain is present in the epigastric region, precardial or 
retrosternal  also it may be referred to left shoulder. If the abscess is 
present in the inferior aspect of the liver it may present as peritonitis of 
upper abdominal pathology. 
 
 
FEVER: 
 
 
Seen in 87-100% of patients(1). It is due to pyrogenic effect of 
necrosed liver cells. Fever is typically between 38
o
C to 40
o
C (1). Mostly 
seen in all patients. 
 
 
RIGOR: 
 
 
Seen in 36-69% (1) of cases associated with fever. 
 
 
NAUSEA AND VOMITING : 
 
 
Seen in 32-85% of cases (1). 
 
 
 
WEIGHT LOSS: 
 
 
Seen in 33-64% of cases. If symptoms are more than two weeks 
patient may present with significant weight loss (1). 
 
DIARROHEA: 
 
 
Seen in one third of the patients. Although the stool microscopy is 
negative in many cases, studies show 75% of the amoebic liver abscess 
patients are positive (19) for parasites in stool microscopic examination. 
 
 
OTHER SYMPTOMS: 
 
 
 Anorexia and acute colitis. 
 
 
 
PULMONARY : 
 
 
Seen in 18-26% of the patients (1).  Rupture of the abscess into the 
pleural cavity causes pleural effusion leads to cough and chest pain. During 
cough odourless brown coloured substance expectorated similar to 
anchovy paste. Reason being bronchopleural fistula. It is nothing, but 
acellular proteinaceous debris consisting of necrotic hepatocytes. 
 
 
 
SIGNS 
 
 
 
ON GENERAL EXAMINATION: 
 
 
Most of the patients are ill health with sweating, anaemic and toxic. 
There will be pain during movements. Some of the patients are 
asymptomatic or may be only associated with fever. 
 
 
 
ABDOMINAL TENDERNESS: 
 
 
It is in the right upper abdominal quadrant .Seen in 55-75% of the 
cases(1). In case of abscess in the left lobe pain will be present in about 
28% of the patients. On percussion there is dullness over the right 
hypochondrium and can detect the vertical dimension of the liver.  
 
 
HEPATOMEGALY: 
 
 
This is generalised soft hepatomegaly sometimes with tenderness. 
May be accompanied with overlying muscle guarding and inter costal 
tenderness, warmthness and cutaneous edema. The usual differential 
diagnosis are acute cholecystitis, hepatitis, pyogenic liver abscess. In the 
situation of atypical presentation it may be confused with simple cyst of 
the liver, hydatid cyst, hepatocellular carcinoma. 
 
 
 
 
JAUNDICE: 
 
 
It is rare. If it is present it indicates the disease is severe. In case of 
large abscess and multiple abscesses and abscess in the inferior aspect of 
the liver they may compress the common bile duct causes jaundice. Seen in 
5% to 8%  of the cases (2). 
 
DULLNESS AND RALES: 
             In the right lung base, breath sounds are decreased. Pleural rub 
may be present. In case of abscess in the left lobe of the liver there may be 
pericardial rub. 
 
 
COMPLICATIONS 
 
 
Communication of the abscess occur in the adjacent structures like 
peritoneal cavity, viscera, large vessels, the pleura, bronchi, lungs and the 
pericardium. 
 
 
PERITONITIS: 
 
 
Peritonitis associated with amoebiasis may be due to rupture of the 
abscess or due to perforation or necrotizing amoebic colitis. The area of 
contamination is confined to the adherence of the liver abscess to the 
anterior abdominal wall, diaphragm, omentum and bowel. Rupture into 
hollow viscus such as stomach and colon may occur in this situation. 
Sudden bloody diarrhoea develops following rupture into the colon. 
Haematemesis seen in situations like rupture into stomach. Rupture into 
the peritoneal cavity causes peritonitis present as guarding and rigidity and 
absent bowel sounds. 
 
PERICARDIAL INVOLVEMENT 
 
 
The left lobe liver abscess is more prone to rupture into the 
pericardial cavity causes asymptomatic pericardial effusion to cardiac 
tamponade. 
 
 
PLEUROPULMONARY  COMPLICATIONS: 
 
 
 
            Rupture of the abscess into the pleural cavity and the bronchial tree 
causes pleural effusion. Clinical presentation will be dry cough and 
dyspnoea which increase the right hypochondrial pain. This rupture of the 
abscess into the pleural cavity occurs suddenly and rapidly causes collapse 
of the right lung and fill the right pleural space. 
 
Rupture of the abscess into the bronchial tree causes sudden cough 
with expectoration containing copious amount of chocolate coloured 
sputum. Although it is a complication of the liver abscess it has the 
beneficial effect due to the abscess drained itself.
PULMONARY AMOEBIASIS : 
 
 
Amoebic abscess of the lungs divided into Primary and Secondary. 
Primary lung abscess is rare and it is due to infection from intestine 
through portal vein into pulmonary capillaries. It causes lung abscess 
independent of  liver abscess. Secondary lung abscess occur from liver by 
direct extension through diaphragm. 
 
 
CEREBRAL AMOEBIASIS : 
 
 
It presents as a complication of liver or lung abscess. It affects one 
of the hemispheres. 
 
 
CUTANEOUS AMOEBIASIS: 
 
 
Adjoining skin is invaded and causes extensive necrosis and slough 
will be formed due to the trophozoites of   Entamoeba histolytica. 
 
 
SPLENIC ABSCESS: 
 
 
It is associated with hepatic abscess by direct extension from 
splenic flexure. 
 INVESTIGATIONS: 
 
 
 
CONVENTIONAL LABORATORY TESTS 
 
 
COMPLETE BLOOD COUNT: 
Blood haemoglobin levels are less than 12g/dl, most of the blood 
picture is normocytic normochromic. Even though there is adequate iron 
storage, sometimes  hypochromic blood picture may exist.(1,19) 
 
Usually neutrophilic leukocytosis will be present. The cell count is 
10,000-20,000/microlitre. Some times leukemoid reactions can occur in 
some cases. Eosinophil count will be normal (4). 
 
Erythrocyte sedimentation rate may be elevated. 
 
 
 
 
LIVER FUNCTION TEST : 
 
 
In acute amoebic liver abscess there will be elevated aspartate 
aminotransaminase (AST) with normal Alkaline phosphatase. In case of 
chronic amoebic liver abscess increased value of alkaline phosphatase and 
normal value of aspartate aminotransaminases (21). There is decreased 
serum albumin level. The bilirubin level may or may not be elevated.       
If it is elevated it shows the disease is severe. The most important test is 
elevated prothrombin time. (25) 
 
 
IMAGING STUDIES  
 
 
CHEST X-RAY : 
 
 
PA view shows elevated right hemi diaphragm seen in 60% of the 
cases(19). It is usually associated with blunting of the right costophrenic 
angle due to pleural effusion, atelectasis of the right lower lobe also due to 
pneumonia. 
 
 
ABDOMINAL X-RAY: 
 
 
Thumb printing in the colon. If there is gas in the abdominal  cavity 
due to hollow viscus perforation or prior percutaneous intervention can be 
diagnosed (21). 
 
 
ULTRASONOGRAPHY: 
 
 
Amoebic liver abscess present as solitary sub capsular lesions. These 
lesions appear in the ultrasound in early stages as hyper echoic lesions than 
adjacent parenchyma. After the necrosis, the abscess core turned into echo 
lucent with posterior acoustic shadow. The advantages are quick, safe, 
economical and easily repeatable, with diagnostic accuracy of 90% (2). 
Many cases can be easily managed with ultrasound alone. It is first line 
disease specific investigation of choice.
The typical findings of hepatic abscess seen in the ultrasound are (21) 
 
 
1) It can detect the location, size, number of the abscess  
 
 
2) A round or oval shape  
 
 
3) The wall echoes are lacking  
 
 
4) Hypo echogenicity compared with normal liver and the diffuse 
echogenicity of the abscess  
 
5) The location is usually periphery and  
 
 
6) The distal sonic enhancement.  
 
 
7) Used as a guide for percutaneous aspiration of the abscess. 
Sometimes hepatocellular carcinoma and metastatic carcinoma may 
be confused with the liver abscess because of their 
hypoechogenisity.  
It is an ideal tool for the follow up of the patients after management.  
 
 
CT SCAN  (1,21,25) : 
 
 
CT Scanning can detect smaller lesions in comparing with 
ultrasound is the major advantage. It is a second line investigation and is 
reserved for patients when ultrasound is not diagnostic. It is useful in 
atypical or chronic abscess cases. CT Scanning shows better enhancement 
of the rim in pyogenic liver abscess and in necrotic liver tumour. In acute 
liver abscess cases,  it does not show any better accuracy than ultrasound. 
It shows abscess as round hypodense lesions which are well defined and 
have homogenous structure. It localises the lesion precisely and shows its 
extent. The disadvantage is more expense and have ionizing radiation. 
 
 
MAGNETIC  RESONANCE  IMAGING: 
 
 
This is not superior to CT Scan in the diagnosis of liver abscess. It is 
mainly used for the follow up of treated patients and to differentiate the 
abscess from neoplasm in the liver. In untreated patients on T1 weighted 
MRI images the abscess cavity appear as hypodense lesions, in T2 
weighted images the abscess cavity appear as hyperdense lesions (15). In 
the abscess margin there will be incomplete ring of hyperdensity. After 
treatment, the cavity in MRI imaging appear as homogenous complete 
concentric rings due to fibrosis and hemosiderin deposits in the peri 
abscess region. After four days of treatment, reparative changes will be 
seen. It indicates the response is good. 
 
Concentric rings seen in the imaging after successful treatment 
corresponds to an inflamed granulation tissue is the inner margin,  the type 
1 collagen represents the next ring, the outer margin corresponds to the 
atrophic or mildly inflamed liver parenchyma became prominent on T1 
and T2 weighted images. The T2 weighted images shows perifocal edema 
and  resolution. Even though these findings are present the pyogenic liver 
abscess, hematomas and necrotic liver tumours have same features . 
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LIVER SCAN: 
 
 
Gallium citrate and technetium labelled sulphur colloid radio 
nucleotide liver scan exhibit ‘cold’ spots for amoebic liver abscess and 
‘warm’spots for pyogenic liver abscess (25). Treated lesions persist as 
cystic appearing lesions, becomes anechoic and calcified. Complete 
radiological resolution occurs after two years or more. Sensitivity >90% . 
 
 
STOOL EXAMINATION  (1,19): 
 
 
  Amoeba in the stool is the confirmatory evidence that the liver 
abscess is due to amoebiasis. Only 10% to 40% of the patients show 
positive microscopic stool examination in case of the amoebic liver 
abscess. It is due to the test may be complicated by the use of laxatives, 
barium, antibiotics and soap water enema. The most efficient method for 
obtaining the specimen for examination is biopsy or scrapping from the 
rectal mucosa during sigmoidoscopy. But the stool examination does not 
distinguish E. Histolytica  from  E. Dispar microscopically. In this 
situation the Enzyme Linked Immunosorbant Assay (ELISA) useful to 
diagnose E.Hitolytica antigens and can differentiate them using stool 
polymerase chain reaction. But the stool examination does not prove or 
exclude the hepatic amoebiasis and invasive disease. 
 
 
 
 
DIAGNOSTIC ASPIRATION: 
 
 
It can be done as ultrasound or CT guided needle aspiration. This 
test is not routinely done. 
 
Therapeutic aspiration is done in following situations (2) : 
 
 
1. In case of inconclusive, delayed or unavailable amoebic serology 
and the differential diagnosis is mainly pyogenic liver abscess  
 
2. In case of suspicious secondary infection of the liver abscess  
 
 
3. A therapeutic trial with anti amoebic drugs is inappropriate, as in 
pregnancy  
 
4. If fever and pain persist for more than 3-5 days even after 
appropriate therapy, may be benefited by aspiration and gives 
symptomatic relief.  
 
5. If the abscess is extremely large, rupture is to be suspected 
especially pericardial rupture in left lobe liver abscess.  
 
 
 
SEROLOGICAL INVESTIGATIONS 
 
 
The serological tests for amoebic infection are highly sensitive and 
specific. This test can differentiate the pyogenic and amoebic liver abscess. 
These tests can also identify circulating amoeba antibodies.  
 
 
The serological tests used are (1,19,21) 
 
1. Indirect haemaglutination test (IHA)  
 
 
2. Counterimmunoelectrophorosis  
 
 
3. Complement fixation  
 
 
4. Immunodiffusion  
 
 
5. Enzyme linked immunosorbent assay(ELISA)  
 
 
In all the invasive infection of the amoebiasis and most of the cases of 
amoebic dysentery are positive for the tests. 
 
The Indirect Haemagglutination test is widely available and highly 
sensitive. The usual serological titre will be 1:512. 
 
The cheap and sensitive technique widely used for serodiagnosis and 
sero epidemiological study is the ELISA. 
 
About 90-95% of the patients are positive for antiamoebic antibodies 
(2) which are detectable after 7 days of infection. If it is positive in 
endemic areas, carefully the case to be investigated because about 35% of 
the patients who are uninfected may have detectable antibodies. But the 
negative serology excludes the disease. In non endemic areas, if the test is 
positive it denotes the disease is confirmed.
TREATMENT 
 
 
Based on epidemiology, clinical features, imaging studies the 
diagnosis can be made and the empirical therapy can be started before the 
confirmatory diagnostic test results come. 
 
 
CONSERVATIVE LINE OF MANAGEMENT (20): 
 
 
     Tissue amoebicides : 

        (i)For both intestinal and extra intestinal amoebiasis 



         Nitroimidazoles: Metronidazole, Tinidazole, Secnidazole, 
 
 Ornidazole, Satranidazole.  

         Alkaloids : Emetine,Dehydroemetine. 


       (ii)For extraintestinal amoebiasis only 


               Chloroquine 


 
Luminal Amoebicides:


 
Amide: Diloxanide furoate, Nitazoxanide 



8-Hydroxyquinolines: Quiniodochlor (iodochlorohydroxyqiun,  
 
    cilioquinol), Diiodohydroxyquin (iodoquinol) 


          Antibiotics: Tetracyclines ,Paramomycin 

 
 
Of which the most commonly used amoebicides are Metronidazoles. 
METRONIDAZOLE (20): 
 
 
It has broad spectrum bactericidal activity against protozoa. 
Metronidazole does not affect aerobic bacteria. They are selectively toxic 
to anaerobic bacteria. After entering into the cell by diffusion its nitro 
group is reduced and forms redox proteins are effective only in anaerobic 
microbes to highly reactive nitro radical which exerts cytotoxicity. It will 
inhibit cell mediated immunity also. It is metabolised mainly in the liver 
primarily by oxidation and glucuronide conjugation and excreted in the 
urine. 
 
Adverse effects : 
 
 
Anorexia, nausea, metallic taste and abdominal cramps are most 
common. Transient neutropenia. In association with alcohol in can cause 
disulfiram-like reactions. 
 
Dosage : 
 
 
For invasive dysentery and Liver abscess – 800 mg tds for 7-10 
days. Cure rate for metronidazole is 90%. No drug resistance has reported 
in Entamoeba histolytica. In case of slow response and relapse, the course 
of therapy can be prolonged. Therapeutic aspiration can be combined with 
prolonged drug therapy. 
EMETINE AND DEHYDRO EMETINE: 
 
 
It is oldest and most powerful drug active against amoebic infection. 
It can be given through intramuscularly and subcutaneously. This drug is 
excreted through kidneys. The mechanism of action is inhibiting the 
protein synthesis. The dose is 1 mg/kg/day for ten days. The most serious 
adverse effect of this drug is cardiotoxicity. 
 
CHLOROQUINE: 
 
 
This is an antimalarial drug, 4 aminoquinoline. It acts by binding 
with deoxy ribonucleic acid of the parasite. It has half life of one week 
mainly it excreted through kidneys. The usual dose is 1g/day for two days 
followed by 500 mg/day for twenty days. 
 
Luminal amoebicides: 
 
 
Following invasive amoebiasis, treatment to eliminate intraluminal 
cyst luminal agents should be given. Paramomycin 25 to 30 mg/kg per day 
orally in three divided doses for seven days. Diiodohydroxyquin 650 mg 
orally daily three times for twenty days to adults or     Diloxanide furoate  
500 mg oraly for ten days. The luminal agents are advised even if the stool 
microscopy is negative. 
ULTRASOUND GUIDED NEEDLE ASPIRATION (8,15) : 
 
 
It is done by using 16G or 18G needle. Widely used for if the abscess 
size is more than 5 cm. Along with drugs more rapid clinical response seen 
in the ultrasound guided aspiration of liver abscess, if the abscess are larger 
in size >5 cm without complications. It is a safe modality of treatment used 
for both diagnostic and therapeutic reasons. It is performed in strict aseptic 
precautions after sonographically identifying the abscess cavity 16 or 18 G 
needle is introduced and pus is aspirated. Repeat ultrasound should be 
done after three to five days and assess the size of the abscess, if it is not 
reducing repeat needle aspiration can be done. It can be repeated up to two 
times, if not reducing it indicates treatment failure and this group of 
patients are preferred for treatment under percutaneous catheter drainage or 
laparoscopic drainage. If the patients are treated by ultrasound guided 
aspiration the advantages are 
 
 The recovery rate is increased  
 Accelerate the resolution  
 Complications less 
 Scar will not be present  
PERCUTANEOUS CATHETER DRAINAGE (10,11) : 
 
 
This method is used when the abscess are large in size of > 5 cm. If 
the ultrasound guided needle aspiration is failed after two attempts 
percutaneous catheter drainage is preferred. Here the abscess cavity is 
assessed and 2% lignocaine is injected under sterile precautions. Needle is 
inserted and the site of abscess cavity is confirmed by aspirating the pus 
and a small incision is made and pigtail catheter is inserted the pus is 
drained and the catheter is fixed to the skin level. Daily the drain output is 
monitored. It is removed after the drain is nil. When compared to 
ultrasound guided needle aspiration this method is better for large abscess 
of size more than 5 cm. 
  
LAPAROSCOPIC  LIVER  ABSCESS  DRAINGE (2,13): 
 
 
This method is an alternative option for percutaneous catheter 
drainage. It provides early recovery, minimal surgical site infection. 
Duration of hospital stay is reduced. It is cosmetically better than open 
drainage methods. Severely ill patients can also tolerate the laparoscopic 
drainage methods. The abscess wall is unroofed by electrocautery or 
harmonic scalpel. In percutaneous drainage method, large bore drain 
cannot be kept. Laparoscopically can place a large bore drain, it has the 
advantage to prevent failure of drainage and the resolution of the abscess 
cavity is faster. 
Advantages 
 
 
 Better localisation of the abscess 


 Better access to difficult sites like dome of the liver and the left lobe 
of the liver. 

 Vascular and biliary structure injuries are avoided 


 Pleural spillage and pneumothorax can be prevented 


 Diagnostic laparoscopy can be done in the same sitting and any intra 
abdominal pathology can be dealt

 Route of drainage can be planned 


 Secondary infections are reduced when comparing open drainage 
methods. 

 Soft large-bore tube drain for better drainage of residual viscid pus 
and necrotic debris 

 Can place the large bore drains in the abscess cavity accurately. 
 
 
 
Disadvantages: 
 
 
 Due to the absence of tactile sensation breakdown of septations and 
perihepatic adhesions are difficult. 
OPEN  SURGICAL  DRAINAGE  METHOD: 
 
 
This method is preferred in case of 
 
 
 Rupture into peritoneal cavity causes peritonitis 


 Rupture into pleural cavity 


 Large abscess cannot be managed with percutaneous drainage 
methods 

 Multiple loculated abscess in the left lobe of the liver 


 When the diagnosis is in doubt 
 
 
PREVENTION (19): 
 
 
  For personal prophylaxis: 
 
 
o Use boiled drinking water 
 
 
o Food and drinks should be protected from contamination by 
flies, cockroaches and rats 
 
 
o Personal hygiene should be maintained.  
 
 
 For community prophylaxis: 


o Effective sanitary disposal of faeces 
 
 
o Protection of water supply from faecal contamination  
 
o Detection and isolation of carriers 
 PYOGENIC LIVER ABSCESS 
 
 
HISTORICAL ASPECTS (1,2,4) 
 
 
Before the advent of the antibiotics, the appendicitis was the most 
common cause of the pyogenic liver abscess. The first documentation is 
ascribed by Waller, French physician in 1846 that the pyogenic liver 
abscess is secondary to appendicitis. He referred this condition as Le foie 
appendiculaire. The first successful treatment for pyogenic liver abscess 
with the use of antibiotic sulfanilamide with surgical drainage for multiple 
liver abscess was reported in 1938 by Oschner and collegues. They also 
reported that amoebic abscess is three times more common than pyogenic 
abscess (2). During the year 1947 anaerobic organisms were cultured and 
treated with penicillin. In the year 1953, McFadzean and colleagues treated 
pyogenic liver abscess with antibiotics and closed tube drainage method. 
 
 
EPIDEMIOLOGY (19,4): 
 
 
It has comparatively higher incidence in neonates those who have 
umbilical sepsis following umbilical vein catheterization. More than sixty 
years age group individuals are commonly affected due to biliary 
pathology. Immuno compromised state and trauma predispose liver 
abscess in adolescents and children. Furthermore, pyogenic liver has no 
gender, racial and geographic difference. 
  
Previously, it was thought to be due to appendicitis causes portal 
pyemia and liver abscess. But now the trend has been changed, common 
etiology is due to biliary tract disease causing ascending cholangitis and 
liver abscess. The frequent cause of the liver abscess due to Streptococcus 
milleri and Escherichia coli. 
 
 
ETIOLOGY (1): 
 
 
BILIARY PATHOLOGY 
 
BENIGN: 
 
 Common bile duct stones 

 Cholecystitis 

 Anastamosis between biliary tract and bowel. 
 
           e.g choledocho duodenostomy 

 Biliary endoscopic procedures like ERCP 

 Percutaneous biliary procedures 
 
 
 
MALIGNANT: 
 
 Periampullary carcinoma 

 Gallbladder carcinoma 

 Pancreatic malignancy 

 Common bile duct malignancy 
 
 PORTAL  ROUTE 
 
BENIGN: 
 
 Diverticular infection 

 Anorectal abscess and other infections 

 Pelvic inflammation 

 Sepsis in the post operative period 

 Perforative peritonitis 
 
 Ulcerative colitis and crohn’s disease 

 Pancreatic abscess 
 
 
MALIGNANT: 
 
 Colonic malignancy 

 Stomach malignancy 

ARTERIAL ROUTE 
 
 Endocarditis 

 Valvular infection 

 Ear, throat and nose infection 

 Dental sepsis. 

TRAUMATIC: 
 
 Blunt and open abdominal injuries 

 Chemoembolization 

 Percutaneous ethanol injection.
 PATHOPHYSIOLOGY (1,24,19): 
 
 
In extrahepatic biliary obstruction by common bile duct stones, 
tumours and strictures causes ascending cholangitis which leads to abscess 
formation in the liver. Portal pyemia following intra abdominal infection 
causes liver abscess via portal circulation 
 
Hematogenous infection via hepatic artery following systemic 
bacterial inection due to bacterial endocarditis, abuse of intra venous drugs 
and urinary sepsis. Trauma and laparoscopic cholecystectomy can cause 
liver necrosis and abscess formation following vascular injury. 
 
Choledocho duodenostomy and choledocho jejunostomy can cause 
liver abscess. Recently,  cryoablation and trans arterial embolization can 
also causes liver abscess. 
 
 
RISK FACTORS (1): 
 
 
 Inflammatory bowel disease. In Crohn’s disease the mucosal barrier 
is destroyed, so more common  than ulcerative colitis. 

 Cirrhotic liver forms a nidus for  infection 


 In transplanted liver 


 In hepatocellular carcinoma of the liver if hepatic artery 
embolization is done, it may predispose liver abscess. 
 
 Immuno compromised states like diabetes mellitus, HIV infection.

 Elder age group 


 Nutritional deficiency, malignancy, pregnancy, corticosteroid use, 
chronic alcoholism are the risk factors for liver abscess. 

MICROBIOLOGY (1,7,19): 
 
 
The  pyogenic  abscess  is  mostly  polymicrobial.  Enteric  facultative 
 
anaerobic organisms  are commonly  involved  in  the pathogenesis.  The 
 
potential pathogens are 
 
 
 Streptococcus milleri or streptococcus anginosus are mainly 
involved in the causation of the pyogenic liver abscess. 

 In case of patients who underwent transarterial embolization for 
hepatocellular carcinoma leads to liver abscess the pathogen 
identified are streptococcus aureus, streptococcus pyogenes.

 Liver abscess can occur following candida infection. 

 Klebsiella pneumonia is isolated from liver abscess of diabetic 
patients in recent times.

 In tuberculous liver abscess, no organisms  isolated 


 In meloidosis liver abscess can occur, it is due to Burkholderia 
pseudomallei. 
  
SPECTRUM OF MICRO ORGANISMS CAUSING PYOGENIC 
LIVER ABSCESS (25) 
 
 
GRAM  POSITIVE  AEROBES 
 
 Streptococcus milleri 

 Staphylococcus aureus 

 Enterococcus 
 
GRAM  NEGATIVE  AEROBES 
 
 Escherichia coli 

 Klebsiella pneumonia 

 Proteus 

 Pseudomonas aeruginosa 

 Enterobacter 

 Citrobacter 
 
GRAM  NEGATIVE  ANAEROBES 
 
 Bacteroides 

 Fusobacterium 
 
 
GRAM  POSITIVE  ANAEROBES 
 
 Clostridium 

  
CLINICAL MANIFESTATIONS (1,20,25): 
 
 
 Fever and abdominal pain are the common symptoms seen in the 
pyogenic liver abscess. Abdominal pain mainly in the right upper 
outer quadrant. In case of left lobe liver abscess pain may be present 
in the epigastric region. 
 
 Chills 


 Weight loss 


 Nausea and vomiting 


 Malaise 


 Cough 


 Referred pain to the right shoulder 


 Pyrexia of unknown origin 


 Loose stools 


 Palpable liver with tenderness 


 Reduced breath sounds in the right lung base, pleural rub may be 
present. 

 Jaundice may be present in 25% of cases due to pre-existing biliary 
disease, large or multiple abscesses compressing the common bile 
duct. 
  
INVESTIGATIONS: 
 
 
 
BLOOD INVESTIGATION  (1,2,4) 
 
 
White blood cell count may be increased. 
 
Because of the chronic pathology, anemia may supervene 
Decreased serum albumin level. Elevated transaminase level may be seen. 
Diabetes mellitus may be associated with pyogenic liver abscess. So the 
blood sugar level should be monitored. 
 
 
PLAIN X-RAY ABDOMEN AND CHEST : 
 
 
It may show air or air fluid levels within the abscess cavity if the 
abscess is due to gas forming organisms (1,21). 
 
 
ULTRASOUND ABDOMEN : 
 
 
Initially the abscess cavity is hyper echoic. It appears as round ovoid 
elliptic lesions within the liver parenchyma. There will be irregular and 
echo poor margins. The abscesses are mostly hypo echoic and contain 
internal echoes of variable in number. If the abscess is due to gas forming 
organisms, the abscess cavity appear as hyper echoic lesions. Sensitivity 
range from 83-95% (1). 
 
Liver abscess may present as single or multiple abscesses. A single 
abscess is cryptogenic. In case of biliary pathology, the abscess will be 
 multiple. In pyogenic liver abscess, if the abscess is less than 2cm in 
diameter described as microabscess (19). There will be two patterns of 
microabscess, one is diffuse military pattern which is seen in abscess of 
staphylococcal origin. The other pattern is cluster pattern which is 
associated with coliform and enteric organisms. In cholangitic abscess 
secondary to biliary obstruction, clustered abscesses occur and are 
multifocal in nature. 
 
 
COMPUTED TOMOGRAPHY : 
 
 
It has the advantage of able to detect the intra hepatic lesions of size 
even if less than 0.5 cm. The pyogenic abscesses are classified according to 
their size into microabscess (<2cm) and macro abscess (>2cm). Micro 
abscess appear as small low density lesions. Around a large abscess small 
daughter abscesses clustered to form multiple liver abscess. This cluster 
sign is suggeative of bacterial etiology.  
 
SCINTIGRAPHY : 
 
 
With technetium sulfur colloid, has sensitive to detect lesions more 
than 2cm in diameter, but smaller lesion may be missed. The advantage is 
the pyogenic liver abscess avidly take up the gallium (1). 
 
 
 
 
 CHOLANGIOGRAPHY (1): 
 
 
To evaluate the patient with liver abscess both endoscopic cholangio 
pancreatography and percutaneous cholangio pancreatography are useful. 
It can identify the anatomy and biliary pathology to rule out ascending 
cholangitis. It also used to decompress the biliary system to relieve 
obstruction and ascending cholangitis. 
 
 
MANAGEMENT 
 
 
Abscess material should be obtained and gram staining to be done 
and the treatment should not be delayed even without culture and 
sensitivity. Related to the common organisms the antibiotics to be started. 
If the abscess is due to biliary pathology it will yield enteric gram negative 
pathogens. In case of colonic disorders, it yield anaerobic pathogens. 
Recently due to the emergence of many resistant bacteria imipenem, 
piperacillin tozabactum, ticarcillin clavulonate, ampicillin sulbactum have 
been recommented. The addition of metronidazole treats bacteroides. This 
is also used in the treatment of amoebic liver abscess. 
 
          Duration and route of administration of the antibiotic therapy 
individualized to the patient according to number of the abscess, 
underlying condition, toxicity of the drugs. 
 
 
 DRAINAGE PROCEDURES : 
 
 
CLOSED ASPIRATION PERCUTANEOUS CATHETER 
 
DRAINAGE : 
 
 
The first closed aspiration was described by McFadzean and 
colleagues in the year 1953. They treated the pyogenic liver abscess 
patients with closed needle aspiration and intracavitory antibiotics (1).  
In percutaneous catheter drainage a pigtail catheter introduced into the 
abscess cavity and the pus is drained under ultrasound guidance. 
 
In patients having Indwelling biliary stents with abscess should be 
treated with systemic antibiotics and stent change, with or without 
drainage. In cholangiography if the abscess is communicating with biliary 
tree, stent change only adequate. If no communication with biliary tract, 
the tract is small and the patient is septic abscess drainage is mandatory. 
 
SURGICAL DRAINAGE: 
 
 
Even though the percutaneous and aspiration techniques are 
developed, surgery also plays vital role in the management of liver 
abscess. 
 
Currently the operations are done through transperitoneal approach 
and drainage of the abscess and correction of the intra-abdominal 
disorders. The incision is made in the midline or subcostally. Thorough 
 exploration of the abdomen is needed before further proceeding. 
The pus should be aspirated and sent for culture and sensitivity. After 
identifying the abscess cavity,  a tract is made through the liver 
parenchyma and the abscess should be drained in a dependent fashion. The 
purulent material should be sucked out. Then the abscess cavity has to be 
enlarged and the loculated cavities are explored. From the wall of the 
abscess cavity biopsies are taken to rule out tumour with necrosis and 
infection and to examine trophozoites of  E. Histolytica.  A  drainage 
catheter should be kept in the cavity to drain the remaining pus. The 
catheters are brought out percutaneously through separate stab incision. 
These drains also used for irrigation, and contrast studies. The omental 
pedicles are kept in the abscess cavity to improve the blood supply. 
  
 
COMPARISION  BETWEEN  AMOEBIC  AND  PYOGENIC  
 
LIVER  ABSCESS (4) : 
 
 
CREITERIA AMOEBIC ABSCESS PYOGENIC ABSCESS 
   
AGE 30 – 50 years >60 years 
   
SEX Males > Females Equal 
   
EPIDEMIOLOGY                Endemic regions May be associated with 
              low socioeconomic liver fluke or round worm 
 status, poor hygiene, Infection 
 Homosexuality  
   
ETIOLOGY                    E. Histolytica Bacterial etiology 
   
ASSOCIATED Rare Biliary tract pathology, 
CONDITIONS  Tumours, diverticulitis, 
  abdominal pathology 
   
JAUNDICE Rare Common 
   
COMPLICATIONS Rupture into adjacent structures Rupture,Msepsis 
   
LIVER FUNCTION Mild derangements. ALP        Markedly abnormal 
TESTS elevated, Albumin reduced Bilirubin, LDH, AST, 
  Globulin are elevated, 
  Albumin reduced 
   
SEROLOGY Positive Negative 
BLOOD CULTURE 
Negative if not secondarily 
Infected Positive 
   
ABSCESS Odourless thick fluid variable Foul smelling pus, creamy 
CONTENTS in colour Yellow 
MEDICAL Always effective Often effective 
 
 
 
 
                                  
 
 
                  
 
 
 
 
 
 
 
 
                    Materials And Methods 
                            
 
                             MATERIALS AND METHODS 
    
 
 
The relevant data shall be collected by using 
 Detailed history 
 Hematological investigations: complete hemogram, liver 
function test, serum proteins and albumin. 
 Coagulation profile – PT ,aPTT, INR  
 Blood culture & sensitivity  
 Stool for ova & cyst 
 Imaging studies : Xray chest , X ray abdomen erect 
 USG abdomen & pelvis – to find echogenicity, site, 
number. 
 CT abdomen &  pelvis – to find exact location, size, 
number, extend ( if needed) 
 All the patients are treated with Inj. Metronidazole 500 mg 
iv tds for 7 – 10 days ( minimum of 5 days) 
 Then the patients are subjected to  various treatment 
modalities like conservative management, USG guided 
 needle aspiration, USG guided  pigtail catheter drainage, 
Laproscopic drainage & laparotomy  
 Follow up USG abdomen after 5 days to look for decrease/ 
increase in abscess size, Recollection after needle 
aspiration. 
 Another follow up USG abdomen done after 6 weeks to 
look for complete resolution of abscess cavity. 
 
Outcomes are studied in terms of  
- Age & Sex distribution 
- Type & Size of abscess 
- Symptoms & Signs 
- Treatment Modalities 
- Clinical improvement 
- Time taken to 50% reduction in abscess cavity size 
- Duration of drainage  
- Duration of hospital stay 
- Complications like infections, hemorrhage & 
rupture 
 - Secondary procedure 
- Serial Follow up for complete resolution of abscess 
cavity 
 
       Patients were  divided into five groups based on size of the 
abscess (i.e. Group I, II, III, IV, V) 
  
 Group I was treated with Drugs alone 
 
 
 Group II was treated with ultrasound guided needle aspiration 
along with  drugs. Maximum of two times repeated aspiration 
was done. 
 
 Group III was treated with pigtail catheter drainage  along with 
drugs 
 
 Group IV was treated with Laparoscopic drainage along with 
drugs 
 
 
 Group V was treated with open surgical method along with 
drugs 
 
 
     Of these groups,  Group I patients are belongs to the abscess 
cavity of size less than 5 cm. They are treated with drugs alone. 
 
     Group II, Group III, Group IV, Group V patients are belongs to 
the abscess cavity of size more than 5 cm and large abscess.
 ADOPTED THERAPEUTIC PROTOCOL 
 
 
1. MEDICAL : 
 
 
All the patients included in the study are treated with drugs 
and additional drainage procedures except the Group I where they 
are treated only with drugs. The antibiotics was started without 
waiting for pus culture and sensitivity reports. 
 
Invariably, Metronidazole 500mg  intravenously three times 
daily, for minimum of five days  given for all the patients. After 
collecting the reports the appropriate antibiotics were given. 
Follow up after 6 weeks done. 
 
 
2. ULTRASOUND GUIDED NEEDLE ASPIRATION : 
 
 
This drainage procedure was done for the patients whom 
abscess size is more than five centimetres. Followed by Inj. 
Metronidazole and antibiotics. 
 
Method: 
 
 
With the help of radiologists, under strict aseptic precaution 
using ultrasound the abscess cavity was localized and injection 
xylocaine 2% was infiltrated percutaneously. Trial aspiration was 
done using 16G or 18G needle. After complete aspiration, dressing 
was applied. The pus was sent for culture and sensitivity. 
 Following aspiration drugs was given for three days. If symptoms 
and signs are not reducing then repeat ultrasound abdomen was 
done and size of the abscess cavity and residual cavity was 
assessed.  If it is increasing in size, second aspiration was done and 
drug therapy was continued. 
 
The advantage of this procedure is patient does not require 
general anesthesia. The scar will not be present, infection rate is 
low. 
 
        The acceptability of the patient is poor in this method due to 
the procedure is painful and distressing, sometimes repeat 
aspiration may be needed. 
 
 
3. PERCUTANEOUS PIGTAIL CATHETER  DRAINAGE : 
 
 
This method is adopted for the patients with abscess cavity 
of size more than 5 centimetres and large abscesses and for those 
who are not fit for general anaesthesia and in mainly right lobe 
liver abscess. 
Method: 
     The abscess cavity is identified either using ultrasonogram or 
eliciting maximum point of tenderness. After localisation of the 
abscess, injection xylocaine 2% was infiltrated locally and trial 
aspiration was done. Then a small stab incision was made, by 
 using artery forceps the abdominal wall was pierced and entered 
into the abscess cavity. A pigtail catheter was introduced and all 
the pus are drained out. The catheter was fixed to the skin using 
non absorbable suture material ( 2-0 silk) and attached to a bag for 
continuous drainage of the pus. 
 
   This method is also does not require general anaesthesia. Major 
amount of the pus can be drained immediately after placing the 
catheter in to the abscess cavity. As the closed tube percutaneous 
drainage method is a crude technique it may cause rupture of the 
abscess into the peritoneal cavity leads to peritonitis. So care 
should be taken during the procedure. 
 
After PCD being done 
 
 
Pus was sent for culture and sensitivity. Empirically 
Injection Metronidazole and antibiotics were started and Daily 
drainage output chart was maintained. Daily dressing was applied. 
Infection of the wound was checked daily and managed. 
 
Removal of PCD  
 
 
If Quantity of discharge  less than 10ml/ day for three days. 
 
 After reassessing  the size of the cavity  by ultrasonogram, PCD 
can be removed  
 
                             USG guided needle aspiration 
    Mr. Krishnan,  39/M , IP.NO:  1654432,  Gp II 
 
 
 
                         Pig tail catheter drainage  
  Mr. Vimalraj,  38/M,   IP.NO: 1654872,   Gp III 
 
 
 
 4. LAPAROSCOPIC DRAINAGE METHOD :  
 
 
 
This modern technique of liver abscess is used for the 
abscess size is more than 5 cm, large abscess. If the percutaneous 
drainage methods and ultrasound guided aspirations methods are 
failed and before opening the abdomen for open drainage 
procedures,  this method can be tried. 
 
Method: 
 
 
 
   Under strict aseptic precaution, in general anaesthesia, a supra 
umbilical 10 mm port was created and carbon dioxide was inflated 
and pneumoperitoneum was created. Telescope was introduced. 
Two working ports were created one in the right hypochondrium 
another one in the left hypochondrium of size 5 mm. Thorough 
examination was done intra abdominal pathology ruled out. If any 
intra abdominal pathology was identified, it should be treated 
along with abscess drainage simultaneously. A wide bore 
abdominal drain tube or catheter was kept in the abscess cavity 
through one of the working ports and the drain brought out to the 
skin and was fixed with non absorbable suture material. The pus 
was sent for culture and sensitivity. If the abscess is loculated, it 
cannot be identified by laparoscopic instruments due to poor tactile 
sensation.  After securing complete haemostasis  the 
 pneumoperitoneum was deflated and the ports was closed with 
absorbable suture materials like Vicryl.   
 
After laparoscopic drainage being done monitor: 
 
 
 The Symptoms 


 Quantity of the drainage 


 Daily pus collection chart 


 Infection of the port site. 
 
   
    Drain was removed after the collection is reduced  
 
below 10 ml for three  consecutive days. 
 
Repeat ultrasound being done after 3 days and the abscess cavity 
size is monitored. 
 
 
5.OPEN DRAINAGE METHOD: 
 
 
 
This method is used in the following situations: 
 
          
(i) Rupture of the abscess into peritoneal cavity  
 
(ii) Multiple abscesses  and   loculated  abscesses  
 
 
    (iii)     Inadequate response to percutaneous drainage


 
 
Under strict aseptic precautions, in general anaesthesia, in 
 supine position midline or subcostal incision was made and skin 
deepened in layers. Thorough laparotomy being done, intra 
abdominal pathology was looked for and managed. The abscess 
cavity was identified and the peritoneal cavity was covered with 
towel to prevent the spillage of the pus and catheter was placed in 
the cavity and brought out to the skin in a separate stab incision. 
The pus was let out and sent for culture and sensitivity. In case of 
ruptured abscess thorough peritoneal wash was given and pelvic 
drain was kept to prevent pelvic abscess. The laparotomy wound 
was closed with non absorbable suture material. Followed by anti 
amoebic and antimicrobials given. After the procedure being done 
following are monitored 
 
 Daily pus collection chart 


 Daily dressing to the wound 


 Infection of the wound site 
 
 
 The abdominal sutures are removed on tenth day.  
 
 Drain was removed after the collection became less than 10ml/day                      
 
 
 
 
 
 
 
    Laparotomy – open drainage 
 
     Mr. Kumar,  40/M,  IP.NO- 1646721 , Gp V 
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                      Key to master chart 
        
ABBREVIATIONS 
   
S.NO          –  SERIAL NUMBER 
IP.NO         –  INPATIENT NUMBER 
M                – MALE 
F                 –  FEMALE 
RT              – RIGHT  LOBE 
LT              – LEFT LOBE 
BB              – BOTH LOBES 
Rx              – TREATMENT 
GP              -  GROUP 
GP  I          – CONSERVATIVE 
GP II          - USG GUIDED ASPIRATION 
GP III         – PIG TAIL CATHETER DRAINAGE 
GP IV         - LAPROSCOPIC DRAINAGE 
GP V          – LAPROTOMY 
CM             -   CENTIMETRES 
D                – DAYS 
IN               -  INFECTION 
HR             –  HAEMORRHAGE 
RT             –  RUPTURE 
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           RESULTS 
             Table – 1 
 
             AGE DISTRIBUTION 
 
                      
 
 
 
   
 
 
 
 
 
                      
                             
0
5
10
15
20
25
30
20 - 30 yrs 31 - 40 yrs 41 - 50 yrs Above 50 yrs
AGERANGE
  AGE NO YES 
20 - 30 yrs 3.8% 7.7% 
31 - 40 yrs 13.5% 36.5% 
41 - 50 yrs 3.8% 17.3% 
Above 50 yrs 5.8% 11.5% 
  
 
 
                                         Table – 2 
                                             
 
                                    SEX   DISTRIBUTION 
 
 
 
 
  
 
 
 
 
 
 
                             
 
                                   
 
8%
92%
GENDER
Female Male
SEX 
 Frequency Percent Valid 
Percent 
Cumulative 
Percent 
Valid Female 4 7.7 7.7 7.7 
Male 48 92.3 92.3 100.0 
Total 52 100.0 100.0  
                                     Table – 3 
 
                            TREATMENT   GROUP 
 
 
                                    Rx GROUP 
  Frequency Percent Valid 
Percent 
Cumulative 
Percent 
Valid GP I 12 23.1 23.1 23.1 
GP II 8 15.4 15.4 38.5 
GP 
III 
26 50.0 50.0 88.5 
GP 
IV 
1 1.9 1.9 90.4 
GP V 5 9.6 9.6 100.0 
Total 52 100.0 100.0   
 
 
 
 
          
 
 
 
0
5
10
15
20
25
30
GP I GP II GP III GP IV GP V
Rx GROUP
                                             
                                        
                                         Table – 4 
 
 
                 ABSCESS – AMOEBIC  OR  PYOGENIC 
 
  
 
AMOEBIC 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid NO 14 26.9 26.9 26.9 
YES 38 73.1 73.1 100.0 
Total 52 100.0 100.0  
 
 
 
 
            
 
 
 
 
 
27%
73%
AMOEBIC
NO YES
  
 
 Table – 5 
 
                                      LOBE   INVOLVEMENT 
 
 
LOBE 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid BB 5 9.6 9.6 9.6 
LT 5 9.6 9.6 19.2 
RT 42 80.8 80.8 100.0 
Total 52 100.0 100.0  
 
 
 
 
 
 
      
               
 
 
                                                   
9%
10%
81%
LOBE
BB LT RT
                                                  
                                                    
                                                   Table – 6 
 
 
                      ABSCESS – SINGLE OR MULTIPLE 
 
 
 
ABSCESS 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid Single 30 57.7 57.7 57.7 
Multiple 22 42.3 42.3 100.0 
Total 52 100.0 100.0  
 
 
 
 
 
 
 
 
                    
58%
42%
ABSCESS
Single Multiple
                                                   Table – 7 
 
                                   SIZE OF CAVITY 
 
 
 
SIZE OF CAVITY 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valids  
< 5 cm 
 
14 
 
26.9 
 
26.9 
 
26.9 
 
5 - 10 
cm 
 
29 
 
55.8 
 
55.8 
 
82.7 
 
10 - 15 
cm 
 
9 
 
17.3 
 
17.3 
 
100.0 
 
Total 
 
52 
 
100.0 
 
100.0 
 
 
 
 
 
 
                   
                                             
                                             
0
5
10
15
20
25
30
< 5 cm 5 - 10 cm 10 - 15 cm
Size
  
                                                Table - 8                           
 
     TIME FOR 50% REDUCTION IN ABSCESS CAVITY 
                                               
 
 
 
 
 
 
 
 
 
 
    
 
     
 
 
 
 
 
 
 
 
 
                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                  
 
 
 
 
 
 
 
 
  
AMOEBIC 
Total NO YES 
TIME FOR 
50% 
REDUCTION 
1 - 5 
days 
Count 5 6 11 
% of 
Total 
9.6% 11.5% 21.2% 
5 - 7 
days 
Count 4 10 14 
% of 
Total 
7.7% 19.2% 26.9% 
7 - 10 
days 
Count 2 16 18 
% of 
Total 
3.8% 30.8% 34.6% 
10 - 
15 
days 
Count 3 6 9 
% of 
Total 
5.8% 11.5% 17.3% 
Total Count 14 38 52 
% of 
Total 
26.9% 73.1% 100.0% 
  
 
 
 
 
 
      
 
0.0%
10.0%
20.0%
30.0%
40.0%
1 - 5
days
5 - 7
days
7 - 10
days
10 - 15
days
TIME FOR 50% REDUCTION WITH 
AMOEBIC
NO YES
  
 
 
                                                 Table – 9 
 
 
                          SECONDARY   PROCEDURE 
 
 
 
                               SECONDARY PROCEDURE 
  Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid NO 47 90.4 90.4 90.4 
YES 5 9.6 9.6 100.0 
Total 52 100.0 100.0   
 
 
 
 
       
90%
10%
SECONDARY PROCEDURE
NO YES
                                                      Table – 10 
  
 
                                                         FOLLOW UP 
 
 
 
 
 
 
FOLLOW UP 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 100% 
resolution 
18 34.6 34.6 34.6 
80% 
resolution 
34 65.4 65.4 100.0 
Total 52 100.0 100.0  
 
 
 
 
 
                               
 
 
 
                                                                           
 
                                                                          
 
                                                       
35%
65%
FOLLOW UP
100% resolution 80% resolution
                                                         Table – 11 
  
               SINGLE/MULTIPLE  VS   AMOEBIC / PYOGENIC 
 
 
 
 
 
 
 
 
                                   
                                     Chi-Square Tests 
 Value Df Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson 
Chi-Square 
10.322a 1 .001   
Continuity 
Correctionb 
8.389 1 .004   
Likelihood 
Ratio 
10.576 1 .001   
Fisher's  
 Exact Test 
   .003 .002 
N of Valid   
Cases 
52     
    
 
                                                               
 
                         
                  P - Value       Highly Significant at P ≤ .01 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
NO YES
ABSCESS WITH AMOEBIC 
Single Multiple
                                                                       Table – 12 
 
              TIME FOR 50% REDUCTION   VS    CAVITY SIZE 
 
 
 
 
 
 
 
 
 
 
 
                    Chi-Square Tests 
 Value df Asymp. 
Sig. (2-
sided) 
Pearson Chi-
Square 
20.832a 6 .002 
Likelihood 
Ratio 
23.950 6 .001 
Linear-by-
Linear 
Association 
.553 1 .457 
N of Valid   
Cases 
52   
          
 
 
 
                               P – Value     Highly Significant at P ≤ .01 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
< 5 cm 5 - 10 cm 10 - 15 cm
TIME FOR 50% REDUCTION WITH SIZE OF 
CAVITY
1 - 5 days 5 - 7 days 7 - 10 days 10 - 15 days
  
                                                                             Table - 13 
 
 
                       RX GP WITH SECONDARY PROCEDURE 
 
 
 
 
 
 
 
                      Chi-Square Tests 
 Value df Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
19.878a 4 .001 
Likelihood 
Ratio 
15.452 4 .004 
N of Valid 
Cases 
52   
 
 
 
 
                   P – Value      Highly Significant at P ≤ .01 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
50.0%
GP I GP II GP III GP IV GP V
Rx GROUP WITH SECONDARY PROCEDURE
NO YES
                  
                       Table – 14 
 
              SINGLE / MULTIPLE ABSCESS   VS   FOLLOW UP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
Single Multiple
FOLLOW UP WITH  ABSCESS
100% resolution 80% resolution
                                          
                                    Chi-Square Tests 
 Value Df Asymp. 
Sig. (2-
sided) 
Exact 
Sig. 
(2-
sided) 
Exact 
Sig. 
(1-
sided) 
Pearson Chi-
Square 
6.692a 1 .010   
Continuity 
Correctionb 
5.253 1 .022   
Likelihood 
Ratio 
6.743 1 .009   
Fisher's Exact 
Test 
   .017 .011 
Linear-by-
Linear 
Association 
6.564 1 .010   
N of Valid 
Cases 
52     
                P – Value Highly Significant at P ≤ .01 
                                                                Table - 15 
 
                         FOLLOW UP  WITH  CAVITY SIZE 
 
 
 
 
 
      
 Chi-Square Tests 
 Value df Asymp. 
Sig. (2-
sided) 
Pearson 
Chi-Square 
6.998a 2 .030 
Likelihood 
Ratio 
8.177 2 .017 
Linear-by-
Linear 
Association 
6.320 1 .012 
N of Valid  
Cases 
52   
     
 
  P – Value                    Significant at P ≤ .05 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
< 5 cm 5 - 10 cm 10 - 15 cm
FOLLOW UP WITH SIZE OF CAVITY
100% resolution 80% resolution
                 
 
 
 
 
 
 
 
 
 
                        Analysis of the Results 
                            
   
                                ANALYSIS OF THE RESULTS 
 
 
TYPE OF THE LIVER ABSCESS: 
 
 
In our study, among 52 patients included of them 73% of the 
patients (38) are amoebic liver abscess and 23% of the patients (14) are 
belongs to Pyogenic liver abscess. The P value is significant ( < 0.001) 
 
This is correlated with other studies  (5, 23) 
 
 
AGE DISTRIBUTION: 
 
 
In our study, most of the patients are within 30- 40 yrs of age. 
amoebic liver abscess are within age group 30 to 50 years. Most of the 
pyogenic liver abscess patients are above 50 years of age group 
 
This study correlates with other studies (6) 
 
 
SEX DISTRIBUTION: 
 
 
In our study, 48 of them are male patients. Only 4 of them are 
females. Most of the male patients are of amoebic liver abscess.  
 
SITE OF THE LIVER ABSCESS: 
 
 
In our study, about 42 patients the liver abscess was found in the 
right lobe of the liver, in five patients in the left lobe of the liver and in 
five patient in both lobes of the liver. It is also correlating with other 
studies (7, 8) 
 SYMPTOMS : 
 
 
In our study, Fever is 100% (all patients) and 85% (44 patients),   
abdominal pain is 86% (45patients) and 93% (48 patients)  of the patients 
in pyogenic liver abscess and amoebic liver abscess respectively. 
 
This study correlates with other studies and shows abdominal pain is 
common in amoebic abscess and fever is common in pyogenic abscess. 
 
SIGNS: 
 
 
In our study, tenderness is 89% (46 patients) and 68 (35 patients), 
jaundice is 8% (4 patients)  and 16% (8 patients),  hepatomegaly is 67% 
(35 patients) and 50% (26 patients ) in amoebic and pyogenic liver abscess 
respectively. 
 
This correlates with other studies and shows tenderness & 
hepatomegaly  is common in amoebic while jaundice is common in 
pyogenic liver abscess.(8) 
 
SINGLE OR MULIPLE ABSCESS: 
                In our study, 30 patients (58%) are of single abscess. 22 (42%) 
of them are pyogenic abscess. Among, single abscess, majority of them are 
amoebic which is about  27 (90%) patients . Only 3 (10%) of them are 
pyogenic. Among multiple abscess, equal distribution seen between 
amoebic & pyogenic.  
          This correlates with other studies shows that majority of single 
abscess are amoebic in nature.  
 
SIZE OF CAVITY: 
                     Among  52  patients, 29  ( 56%) of them  are of size 5-10 cm. 
14 patients ( 27% ) are < 5 cm of size.  9 patients ( 17% ) are of 10-15 cm 
size. 
 
TREATMENT MODALITIES: 
 
 
            Five modes of treatments are available.  In our study, about 12 
patients are in group I they treated by drugs alone. 8 patients in group II, 
are treated by ultrasound guided needle aspiration with drugs. In group III, 
about 26 patients are treated with percutaneous catheter drainage method. 
In group IV, about 1 patient  treated with laparoscopic drainage  method. 
In group V, about 5  patients are treated with open surgical drainage 
method. 
 
DURATION OF DRAINAGE: 
             Among treatment modalities, pigtail catheter drainage accounts for 
about minimum of 8- 10 days. It increases in case of complications. In 
laparotomy & laproscopic drainage  it accounts for slightly earlier duration 
about 5-7  days. 
 
 50% REDUCTION OF THE ABSCESS CAVITY: 
 
              In our study,  In group II  among 8 patients, 6 of them reduction 
seen in 5-7 days, but secondary procedure is more in this group. In group 
IV & V majority of them are within 1-5 days except in case of 
complications. In group III, majority of them are in 5-7 days.  
 Overall, duration of 50% reduction among all groups is about 7-10 days. 
 
 
 
DURATION OF HOSPITAL STAY: 
 
 
In our study, most of the patients (19) treated with pigtail catheter 
drainage method had 7-10  days hospital stay. Most of the patients (6) 
treated with ultrasound guided aspiration had hospital stay varies from 10-
12 days. For laparotomy, hospital stay varies from 10 - 15 days, which is 
slightly higher compared to other groups. 
 
This study correlates with other studies (11,12) 
 
 
 
SECONDARY PROCEDURE DONE: 
 
 
In our study about 8 patients in group II, 3 of them undergone  
secondary procedure like repeat needle aspiration & pigtail drainage. In 
group I, one patient had secondary procedure. No patients was undergone 
secondary procedure in pig tail catheter method.  
It correlates with other studies. 
 COMPLICATIONS: 
 
 
In our study, Infection was seen in 12% (6) of patients. 
Haemorrhage seen in 2% (4) of patients. Rupture seen in 4% (8) of 
patients. 
Infection mainly seen in Gp III ( 2 patients) & Gp V ( 3 patients). 
Haemorrhage seen in Gp III ( 2 patients). 
Rupture seen in Gp II & Gp III ( 1 patient each)   
 
This study correlates with other studies (13) 
 
 
 
FOLLOW UP : 
 
 
In our study nearly 100% resolution  seen in only 18 patients (35%). 
80% Resolution seen in patients 34 patients (65%).  
Among group V, all of them are having nearly 100% resolution. 
 In  group III , 80% resolution (17 patients) and 100% resolution ( 9% 
patients). In group II,  majority of them are in 80% resolution rate.   
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
                                          Discussion 
 
                                          DISCUSSION 
 
             Fifty two  cases of liver abscess were randomly selected for the 
study in the year between Februry 2016 to September 2016 in Government 
Stanley hospital, Chennai regarding their age, sex, type of the abscess, 
symptoms, signs, treatment modalities, reduction of the abscess cavity 
more than 50% in days, duration of hospital stay, secondary procedure 
required, complications and resolution rate and  are studied. 
 
 
TYPE OF THE ABSCESS : 
 
 
Worldwide the most common type of liver abscess is due to 
amoebiasis called amoebic liver abscess. In developed western countries, 
the common etiology for liver abscess is due to bacteria called pyogenic 
liver abscess. Still in India and also in other developing countries amoebic 
liver abscess is common. Also in temperate climate countries where the 
sanitation is poor and overcrowded area and unhygienic practices are 
followed this amoebic liver abscess is commonly present. In developed 
countries where the sanitation is good there is less chance for amoebic 
liver abscess. Fungal and tuberculous diseases are also causing liver 
abscess. But no case was reported in our study. 
 
In comparing with other studies our study also conclude that amoebic liver 
abscess is common type in India.(5,23) 
 AGE DISTRIBUTION : 
 
 
Amoebic abscess is due to the parasite E.Histolytica where the 
infective form cyst is present in the contaminated water causing 
amoebiasis. It becomes invasive disease, when the liver gives area for 
seeding. In India, most of the young individuals are affected between the 
age group 30 years to fifty years those who are alcoholic and living in 
overcrowded area with poor sanitation. Alcohol causes hepatocellular 
damage and make a nidus for infection. 
 
Instead, the older individuals more than sixty years of age group are 
commonly affected by pyogenic liver abscess mainly due to biliary tract 
disease. In earlier days, it was due to appendicitis leads to portal pyemia 
and liver abscess. 
 
In comparing with other studies (8) regarding age distribution of the 
liver abscess the amoebic liver abscess common in younger age group and 
pyogenic abscess common in elder age group.  It correlates with our study. 
 
SEX RATIO : 
 
 
When comparing females, most of the males are consuming alcohol. 
So, the alcohol induced liver damage is common in male population leads 
to the increased incidence of amoebic liver abscess in men in India. The 
Amoebic abscess is seven to ten times  common in men than in women.  
 
 But there is equal incidence in both males and females in case of 
pyogenic liver abscess. 
 
In our study in amoebic liver abscess commonly affecting the males. 
It correlates with other studies (5,23) 
 
SITE OF THE LIVER ABSCESS : 
 
 
Because of large volume and the increased blood flow to the right 
lobe of the liver the infection seeding occurs most commonly in the right 
lobe of the liver. Most of the study says that the right lobe is commonly 
involved. Our study (7,8) also correlates. 
 
In our study, for all the cases ultrasonogram was done where the 
abscess was found commonly in the right lobe in most of the cases. 
 
 
SYMPTOMS: 
 
 
ABDOMINAL PAIN: 
 
 
The pain in the right hypochondrial region is due to stretching of the 
liver capsule by the abscess cavity. If the abscess is large enough to stretch 
the capsule may cause pain and if it is smaller the pain is uncommon. In 
case of right lobe liver abscess the pain was referred to right shoulder. In 
case of left lobe abscess the pain was referred to epigastriun or to the 
precardiac region. 
  
In our study most of the liver abscess in the right lobe of the liver 
and most of the patients with pain in the right hypochondrial region. When 
comparing with other studies our study is correlated.(5,8) 
 
FEVER: 
 
 
In comparison with amoebic liver abscess, pyogenic liver abscess 
has slightly higher incidence of fever. In our study all the cases of 
pyogenic liver abscess are having fever whereas in amoebic liver abscess 
85% of the patients are found to have fever. 
 
This is also correlating with our studies(5,8) 
 
 
 
SIGNS: 
 
 
TENDERNESS: 
 
 
The right hypochondrial tenderness is frequently associated with 
liver abscess particularly in amoebic liver abscess. Inter costal tenderness 
can be elicited in many patients. In our study most of the amoebic liver 
abscess patients are associated with tenderness. 
 
This result is also correlating with other studies.(8) 
 
 
 
JAUNDICE: 
 
This is common in patients with pyogenic liver abscess because the 
biliary tract disease is the most common etiology. This is due to 
compression of the common bile duct by multiple abscess or large abscess. 
 Mild jaundice is seen in case of amoebic liver abscess. 
 
 
HEPATOMEGALY : 
 
 
If the abscess size is larger, the liver is palpable clinically. 
Ultrasound can also identify the hepatomegaly and abcess size. Most of the 
patients with amoebic liver abscess having hepatomegaly. Sometimes the 
pyogenic liver abscess show hepatomegaly. 
 
 
INVESTIGATIONS 
 
 
Blood haemoglobin, Blood sugar, White blood cell count, Liver 
function test are done routinely for all the patients included in the study.  
Increased alkaline phosphatase, increased bilirubin and decreased albumin 
levels are seen in patients with amoebic liver abscess. Anemia was seen in 
half of the patients in the study group. The leukocytosis was observed in 
three fourth of the patients in both groups. 
           Chest X-ray PA view was taken to all the patients. 
 
 
           Ultrasound abdomen was done to all the patients to know the size, 
number, location of the abscess cavity and rupture of the abscess and intra 
abdominal pathology. CT Scan was required for four of our patients, 
included in the study. 
 
 
 TREATMENT MODALITIES: 
 
 
In our study, for all the patients ultrasonogram was done. The 
location, size, site of the abscess cavity was identified. The patients 
included in the study was divided in to five groups. 
 
The group I patients were treated with drugs alone and they have 
abscess size of less than five centimetres. The group V patients are treated 
by open surgical method followed by drugs. These patients are treated in 
emergency situations. Group II, Group III, Group IV patients are 
categorized based on the abscess size more than 5 centimetres and large 
abscess. These three group patients are compared because the three 
modalities of treatments like ultrasound guided needle aspiration, 
percutaneous catheter drainage, laparoscopic drainage methods can be 
applied to all these groups. So, in the following aspects these groups are 
studied 
 
 More than Fifty percent reduction of the abscess cavity in how 
many days 
 
 Duration of hospital stay 


 Secondary procedure done or not 


 Complications like  (1) Infection (2) Hemorrhage (3)  Rupture 


 Resolution rate 
 
  
MORE THAN 50% REDUCTION IN THE ABSCESS CAVITY: 
 
 
In group II, for aspiration wide bore needles are used. In some 
instances pus may be thick so some amount of pus may be retained in the 
abscess cavity. In this situation,  reduction of the abscess cavity may be 
delayed. This is identified by repeat ultrasound after 5 days of treatment. 
In group III and IV patients the abscess cavity is reduced earlier than the 
group II because there wide bore drains are used. 
 
In percutaneous catheter drainage method and laparoscopic drainage 
methods large amount of pus can be drained in single aspiration so the 
reduction of the abscess cavity is higher. As there is continuous drainage 
of the pus the reduction and resolution of the abscess cavity is faster. 
 
This is correlated to other studies when comparing with our studies. 
(9,10,11) 
 
DURATION OF HOSPITAL STAY: 
 
 
           In group I,  the patients are treated with intravenous antibiotics for 5 
days in the hospital and discharged and oral antibiotics were given for one 
week and reviewed with ultrasound followed by decision was made 
whether further treatment is required or not. In group II patients, 
ultrasound guided aspiration was done followed by drugs are given. Then 
repeat ultrsonogram was done in 3-5days,  followed by further treatment 
 was decided and post procedure hospital stay durations are recorded. In 
group V patients postoperative hospital day duration was longer due to the 
open surgical procedure, general anesthesia, wound infection, need for 
intravenous antibiotics. 
           Comparatively, in laparoscopic drainage method has the advantage 
of shorter duration of hospital stay due to early reduction of the abscess 
cavity. Recovery from the symptoms and signs in ultra sound guided 
aspiration and the time taken for reduction of the abscess cavity is longer. 
Also, need for secondary procedure is high in ultrasound guided aspiration. 
In percutaneous catheter drainage method hospital stay is slightly higher 
than laparoscopic method due to there may be missed abscess cavities and 
also infection rate is high. This study also correlates with other studies 
(11,12). 
 
SECONDARY PROCEDURE DONE: 
 
 
It is done for patients those who have residual cavity, and the 
recurrence of the disease. In our study most of the patients in group II were 
required secondary procedure due to thick pus in the abscess cavity, 
improper intake of antibiotics, and irregular follow up. One patient in 
conservative management was required secondary procedure due to 
residual cavity. No patient in group III  required secondary procedure. 
 
This also correlates with other studies (13). 
 COMPLICATIONS: 
 
 
INFECTION: 
 
 
Infection rate is higher in group V patients. Because the open 
surgical techniques are more prone for infection than any other procedures. 
Infection may be due to unsterile techniques and contamination of the 
surgical wound by the pus. In closed tube percutaneous catheter drainage 
method,  peritoneal spillage of the pus may occur. In this method also 
infection rate is relatively higher in comparing group II and group IV 
patients. Due to the infection the duration of the hospital stay and the use 
antibiotics are increased. 
 
HEMORRHAGE: 
 
 
This complication is common in case of ultrasound guided 
aspiration and percutaneous catheter drainage methods due to direct 
visualisation is not there during the procedures. In laparoscopic and open 
drainage methods, direct visualisation is possible. Hemorrhage can occur 
in the abdominal wall or the abscess cavity. 
 
RUPTURE: 
 
 
This is rupture in to the peritoneal cavity during insertion of the 
drainage tube in to the abscess cavity. It may cause peritonitis.  
 
 RECOVERY RATE AND RESOLUTION TIME: 
 
 
It is based on the patient’s general condition, associated pathology in 
the biliary tree, size of the abscess, number of the abscess, treatment opted, 
postoperative care. If the patient in immune compromised like anaemia 
diabetes mellitus, patients on steroid therapy, patients on chemotherapy and 
patients with HIV infection the rate of the healing of the abscess may be 
delayed.  
 
Associated biliary pathology delays the recovery due to ascending 
cholangitis, it presents as a nidus for infection. In case of amoebic liver 
abscess, intestinal amoebiasis should be treated also.  
 
Treatment should be planned according to the size of the abscess, 
general condition the clinical presentation at the time of admission. Correct 
treatment option can increase the recovery rate markedly. After surgical 
drainage procedures appropriate antibiotics, adequate nutrition, other post 
operative care measures to minimise the infection can increase the 
recovery. 
          In our study early resolution is seen in the patients whom treated 
with laproscopic & laprotomy drainage procedures.  
         This is correlating with other studies (10,11,15,16). 
  
 
 
 
 
 
 
 
 
                    Summary  
 SUMMARY 
 
 
• In the 52 cases,  38 cases are having amoebic liver abscess and 12  
          patients are having pyogenic liver abscess.  
• Amoebic liver abscess is commonly seen in the age group between 30- 
50 years and the pyogenic liver abscess commonly seen in the age 
group more than 50 years 
•  In amoebic liver abscess,  males are commonly affected than the 
females. Most  of them are  single abscess cavity ( 52%) 
• All the patients included in the study are belonging to low 
socioeconomic groups.( Jarumillinta et al 2002 WJE 2002)  
• Right lobe abscess in 42 patients, left lobe abscess in 5 patients , both 
lobes abscess in 5 patients. ( Rustagi et al AGE  2006) 
 
• In amoebic liver abscess 85.7% patients are having abdominal pain. It is  
           higher than pyogenic liver abscess. Fever is seen all the patients of  
           pyogenic liver abscess.   
• Tenderness and hepatomegaly is common in amoebic liver abscess and  
           jaundice is common in pyogenic liver abscess patients 
•  < 5cm abscess the treatment is drugs alone. Metronidazole for amoebic  
           abscess and antimicrobials for pyogenic abscess.  
• >5cm abscess  - ultrasound guided aspiration, percutaneous catheter  
            drainage, laparoscopic drainage method, laparotomy. 
  
• 26 Patients were undergone pigtail procedure ( 50%) 
• Among abscess cavity, single abscess( 30 patients) more than multiple. 
Most of the single abscess cavity  belongs to amoebic type 
• Among cavity size 5-10 cms  is more common ( 29 patients). 
• Time taken for 50% reduction of cavity size commonly falls between 7-
10 days. 
• Only 10 patients undergone secondary procedure 
• Only 65% patients achieve almost complete remission by 6 weeks follow 
up. 
• Among size of cavity, < 5cm take longer time for 50%reduction 
compared to 5-10 cm since intervention is carried out. 
 
• In pigtail drainage method 50% reduction of the abscess cavity seen  in 
most of the patients with in 5-7 days, in needle aspiration similar  
reduction but secondary procedure is more  
• The duration of hospital stay is 7-10 days  in percutaneous catheter 
drainage, 10- 12 days in needle aspiration method.  
•  Two third of the patients required secondary procedure in ultrasound 
guided needle aspiration.  
• Conservative line of treatment – 100% resolution of abscess cavity is less. 
                                          
 
  
                               
 
 
 
 
 
                                              Conclusion 
  
                                                   CONCLUSION 
 
 
In case of abscess size is less than 5 cm, drugs alone is enough. 
 
 
If the abscess size is more than 5 cm and large abscess without 
complications any one of the following method of treatment options may be 
carried out 
 
1. Ultrasound guided needle aspiration with drugs  
 
 
2. Percutaneous catheter drainage method with drugs  
 
 
3. Laparoscopic drainage method with drugs 
  
 
 
 
 
• Among these, pig tail drainage is most common procedure carried out in 
our institution. Except for increased hospital stay, being simple & 
effective, it remains the gold standard treatment of choice currently. 
•  In selected cases,  Laproscopic drainage may be an effective alternative 
for large abscess with strong walls, multiple chambers which cannot be 
fully drained. 
           Sample size is inadequate for interpretation in my study. 
• If the abscess has ruptured with peritonitis, open surgical method is best 
method. 
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 “A Comprehensive study on various treatment modalities 
& its outcome in liver abscess in our institution” 
 
                                                     PROFORMA  
 
NAME:                                                  AGE :                                    SEX:  
OCCUPATION:                                    IP.NO:                                   DOA: 
SOCIOECONOMIC STATUS:  
 
PRESENT HISTORY :  
    ABDOMINAL PAIN  
    FEVER  
    NAUSEA & VOMITING  
    DIARROHEA  
    JAUNDICE  
 
PAST HISTORY:  
  
PERSONAL HISTORY :  
   ALCOHOLISM  
   SMOKING  
 
GENERAL EXAMINATION :  
    PALLOR  
   JAUNDICE  
   TEMPERATURE  
 PER ABDOMINAL EXAMINATION :  
   GUARDING & RIGIDITY  
   RIGHT HYPOCHONDRIAL TENDERNESS  
   INTERCOSTAL TENDERNESS  
   HEPATOMEGALY  
 
INVESTIGATIONS :  
BLOOD :  
    HAEMOGLOBIN  
    SERUM BILIRUBIN  
    SERUM ALBUMIN  
    SGOT  
    SGPT  
    ALP 
PUS C/S : 
STOOL FOR OVA / CYST : 
 
CHEST-X-RAY  :  
 
ULTRASONOGRAM:  
   SITE OF THE ABSCESS   
   SIZE OF THE ABSCESS 
   NUMBER OF THE ABSCESS 
  
CT SCAN :       
 TREATMENT MODALITIES :  
                
     CONSERVATIVE                                  
     USG GUDED NEEDLE ASPIRATION  
     PIGTAIL CATHETER DRAINAGE         
     LAPROSCOPIC DRAINAGE                
     LAPROTOMY                                        
 
  OUTCOMES :  
 
     CLINICAL IMPROVEMENT                  
     DURATION OF DRAINAGE                 
     TIME FOR 50% REDUCTION OF  ABSCESS  CAVITY                   
     DURATION OF HOSPITAL STAY        
     SECONDARY PROCEDURE   
     COMPLICATIONS                                   
     RECURRENCE                                     
     FOLLOW UP                                         
     
 DATE OF DISCHARGE :                       
 
 
  
 
 
 
 
 
 
 
 
                                         Consent Form
     GOVT.STANLEY MEDICAL COLLEGE, CHENNAI- 1. 
   
                                                         INFORMED CONSENT 
 
DISSERTATION TOPIC:   
“A Comprehensive study on various treatment modalities 
& its outcome in liver abscess in our institution” 
PLACE OF STUDY: GOVT. STANLEY MEDICAL COLLEGE, CHENNAI 
NAME AND ADDRESS OF PATIENT: 
 
 I, _____________________ have been informed about the details of the study 
in my own language. 
 
I have completely understood the details of the study. 
 
I am aware of the possible risks and benefits, while taking part in the study. 
 
I understand that I can withdraw from the study at any point of time and even 
then, I will continue to receive the medical treatment as usual. 
 
I understand that I will not get any payment for taking part in this study. 
 
I will not object if the results of this study are getting published in any medical 
journal, provided my personal identity is not revealed. 
 
I know what I am supposed to do by taking part in this study and I assure that I 
would extend my full co-operation for this study. 
 
Name and Address of the volunteer :                            Signature of investigator : 
               
Signature/Thumb impression of the Volunteer 
Witnesses: (Signature, Name & Address)                     Date: 
 
 
 அரசு.ஸ்டான்லி மருத்துவ கல்லூாி, சென்னை – 1 
  “A Comprehensive study on various treatment modalities 
& its outcome in liver abscess in our institution”      
 
நான் இந்த ஆராய்ச்ெியில் விவரங்கனை முற்றிலும் புாிந்துசகாண்டடன். 
ஆய்வில் பங்கு எடுத்துடபாது, ொத்தியமாை அபாயங்கள் மற்றும்  பயன்கனை பற்றி  
நான் அறிந்துள்டைன். 
நான் எந்தசவாருடவனையிலும் ஆய்வில் இருந்து திரும்பமுடியும. அதன்பின்ைர், நான் 
வழக்கம் டபால் மருத்துவ ெிகிச்னெ சபற முடியும் என்று புாிந்து சகாள்கிடறன் 
நான் ஆய்வில் பங்கு எடுத்து பணம் எனதயும் சபறமுடியாது என்று அறிந்துள்டைன். 
இந்த ஆய்வின் முடிவுகள் எந்த சமடிக்கல் ஜர்ைலில் சவைியிடப்பட இருந்தால் நான் 
எதிர்க்கவில்னை, என் தைிப்பட்ட அனடயாைத்னத சவைிப்படுத்தப்பட்டு 
இருக்ககூடாது. 
நான் இந்த ஆய்வில் பங்சகடுப்பதன் மூைம் நான் என்ை செய்ய டபாகிடறன் என்று 
சதாியும் 
நான்  இந்த ஆய்வில் என் முழுஒத்துனழப்னபயும் சகாடுப்டபன் என்று 
உறுதியைிக்கிடறன். 
 
தன்ைார்வைர்       ொட்ெி  
சபயர் மற்றும் முகவாி                 சபயர் மற்றும் முகவாி 
னகசயாப்பம் / விரல்டரனக:      னகசயாப்பம் / விரல்டரனக: 
 
 
 
ஆராய்ச்ெியாைராக  னகசயாப்பம் மற்றும் டததி 
 
                                           
  
 
 
 
 
 
 
 
 
 
 
 
 
 
